28 Feb 2023
35 million EUR from EU and Czech Republic to etablishment of research centre focused on the development of advanced cell and gene therapies
Thanks to €35 million funding from the European Union and the Czech Republic, Central European Advanced Therapy and Immunotherapy Centre (CREATIC) will start its activities from 1 September 2023. CREATIC focuses on undiagnosed untreatable rare diseases, paediatric patients with high-risk tumours, and adult cancer patients suitable for Advanced Theraphy Medicinal Products (ATMP) treatment.